PEOPLE - Dendritic NanoTechnologies (DNT) makes appointment:
This article was originally published in Clinica
Dendritic NanoTechnologies (DNT), of Mount Pleasant, Michigan, which specialises in advanced dendritic polymers, has appointed Michael Pirc to its board of directors. Mr Pirc, formerly with DNT partner company Dow Chemical Licensing, will identify potential licensing arrangements for the company's technology. A chemical engineer, Mr Pirc was formerly head of technology licensing at Dow.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.